Published in Transplantation on September 01, 1992
Expression of functional CD40 by vascular endothelial cells. J Exp Med (1995) 2.16
Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease. Gut (1995) 1.09
Cyclosporin A differentially inhibits multiple steps in VEGF induced angiogenesis in human microvascular endothelial cells through altered intracellular signaling. Cell Commun Signal (2004) 1.02
Leukocyte integrin Mac-1 promotes acute cardiac allograft rejection. Circulation (2008) 1.01
Altered expression of cell adhesion molecules in uninvolved gut in inflammatory bowel disease. Clin Exp Immunol (1993) 0.97
Endothelial and smooth muscle cells express leukocyte adhesion molecules heterogeneously during acute rejection of rabbit cardiac allografts. Am J Pathol (1994) 0.96
The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities. Am J Clin Pathol (2009) 0.94
Patterns of myocardial cell adhesion molecule expression in human endomyocardial biopsies after cardiac transplantation. Induced ICAM-1 and VCAM-1 related to implantation and rejection. Am J Pathol (1994) 0.88
Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-alpha or IL-4 and is not required for allograft rejection. Am J Pathol (1995) 0.87
Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury. Methods Mol Biol (2013) 0.84
How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Am J Pathol (1995) 0.82
Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Roles for TNF and IL4. Am J Pathol (1995) 0.80
Hypothermic preservation of lung allograft inhibits cytokine-induced chemoattractant-1, endothelial leucocyte adhesion molecule, vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression. Clin Exp Immunol (2007) 0.79
Inflammatory cytokines and atrial fibrillation: current and prospective views. J Inflamm Res (2010) 0.75
Pancreatic allografts: identification of useful biomarkers of rejection and beyond. Dig Dis Sci (2014) 0.75
A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol (1992) 3.85
The Nottingham Health Profile as a measure of quality of life following combined heart and lung transplantation. J Epidemiol Community Health (1988) 3.35
Asymmetric redirection of flow through the heart. Nature (2000) 2.99
Peanut lectin binding properties of germinal centres of mouse lymphoid tissue. Nature (1980) 2.79
The human myocardial two-dimensional gel protein database: update 1994. Electrophoresis (1994) 2.57
Spatiotemporal relation between gap junctions and fascia adherens junctions during postnatal development of human ventricular myocardium. Circulation (1994) 2.21
5-Hydroxytryptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovasc Res (1990) 2.16
Altered connexin expression in human congestive heart failure. J Mol Cell Cardiol (2001) 2.15
The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol (1993) 2.13
Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann N Y Acad Sci (1992) 2.06
Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet (1990) 2.04
Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet (1996) 1.95
Antigenic heterogeneity of vascular endothelium. Am J Pathol (1992) 1.85
Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans. Circulation (1998) 1.79
Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J Exp Med (1990) 1.77
Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol (1993) 1.77
Migration of lymphoblasts to the small intestine. II. Divergent migration of mesenteric and peripheral immunoblasts to sites of inflammation in the mouse. Cell Immunol (1976) 1.68
Cyclin-dependent kinase inhibitor expression in human heart failure. A comparison with fetal development. Eur Heart J (1999) 1.60
Successful double-lung transplantation with direct bronchial artery revascularization. Ann Thorac Surg (1993) 1.60
Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation (2001) 1.56
Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching. Lancet (1995) 1.55
High molecular weight kininogen deficiency: a patient who underwent cardiac surgery. Thromb Haemost (2001) 1.52
Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation (2001) 1.52
Specialist surgery in the developing world: luxury or necessity? Anaesthesia (2007) 1.52
Anatomy of the coronary arteries in transposition of the great arteries and methods for their transfer in anatomical correction. Thorax (1978) 1.51
Anatomy of the muscular subpulmonary infundibulum with regard to the Ross procedure. Ann Thorac Surg (2000) 1.51
Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders. Lancet (1985) 1.51
Endothelial function of human gastroepiploic artery. Implications for its use as a bypass graft. J Thorac Cardiovasc Surg (1991) 1.50
Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation (2001) 1.46
Left atrial tamponade. Thorax (1966) 1.45
Immunocytochemical changes suggestive of damage to endothelial cells during rejection of human cardiac allografts. Transplantation (1990) 1.43
Heterotopic cardiac transplantation in infants and children. J Thorac Cardiovasc Surg (1997) 1.43
Valve interstitial cells induce donor-specific T-cell anergy. J Thorac Cardiovasc Surg (2001) 1.43
Development of an opiate-based anaesthetic technique for use in dogs with cardiomyopathy. Vet Rec (1991) 1.42
Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography. J Am Coll Cardiol (1997) 1.42
Naive neutrophils and xenotransplantation. Lancet (1996) 1.41
Two-stage operation for anatomical correction of transposition of the great arteries with intact interventricular septum. Lancet (1977) 1.41
Retransplantation in heart-lung recipients with obliterative bronchiolitis. J Thorac Cardiovasc Surg (1994) 1.39
Dipyridamole vasodilator response after human orthotopic heart transplantation: quantification by oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol (1992) 1.38
Gianturco self-expanding metallic stents in treatment of tracheobronchial stenosis after single lung and heart and lung transplantation. Eur J Cardiothorac Surg (1991) 1.38
Magnetic resonance characterization of pulmonary arterial blood flow after single lung transplantation. J Thorac Cardiovasc Surg (1991) 1.38
End-stage dilated cardiomyopathy. Persistence of enterovirus RNA in myocardium at cardiac transplantation and lack of immune response. Circulation (1989) 1.36
Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest (1996) 1.35
Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler Thromb Vasc Biol (1999) 1.35
Non-invasive mechanical ventilation for cystic fibrosis patients--a potential bridge to transplantation. Eur Respir J (1991) 1.35
Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol (1998) 1.34
Role of potassium channels in bronchodilator responses in human airways. Am Rev Respir Dis (1992) 1.33
I. Effect of Trichinella spiralis infection on the migration of mesenteric lymphoblasts and mesenteric T lymphoblasts in syngeneic mice. Immunology (1976) 1.32
A new technique for replacement of the mitral valve by a semilur valve homograft. J Thorac Cardiovasc Surg (1969) 1.30
Hematoma of the interatrial septum with heart block secondary to dissecting aneurysm of the aorta. A clinicopathologic entity. Circulation (1972) 1.26
Anatomical correction of complete transposition of the great arteries and ventricular septal defect in infancy. Br Med J (1976) 1.25
Opening and closing characteristics of the aortic valve after different types of valve-preserving surgery. Circulation (1999) 1.24
Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br J Pharmacol (1997) 1.24
C4d fixing, luminex binding antibodies - a new tool for prediction of graft failure after heart transplantation. Am J Transplant (2007) 1.24
Candida endocarditis after heart surgery. Thorax (1968) 1.23
Early and long-term results of a valve-sparing operation for Marfan syndrome. Circulation (1999) 1.23
De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival. Am J Transplant (2011) 1.22
Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis. Carcinogenesis (2000) 1.21
Cardiorespiratory responses to exercise training after orthotopic cardiac transplantation. Circulation (1988) 1.19
Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation (1996) 1.18
Aortic homograft replacement of the mitral valve in sickle cell trait. J Thorac Cardiovasc Surg (1970) 1.18
Troponin I gene expression during human cardiac development and in end-stage heart failure. Circ Res (1993) 1.18
Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant (2004) 1.17
Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro. J Clin Invest (1993) 1.17
Immunohistochemical demonstration of human cardiac innervation before and after transplantation. Circ Res (1990) 1.16
Heat shock protein 70 gene transfection protects mitochondrial and ventricular function against ischemia-reperfusion injury. Circulation (2001) 1.15
Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. J Chromatogr (1990) 1.15
Cardiovascular effects of intravenous salbutamol after open heart operations. Lancet (1973) 1.15
Isolation and characterization of the human cardiac troponin I gene (TNNI3). Genomics (1996) 1.14
Vascular endothelial growth factor release following coronary artery bypass surgery: extracorporeal circulation versus 'beating heart' surgery. Eur Heart J (2000) 1.14
Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. Circulation (2000) 1.14
Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor. J Neuroimmunol (1997) 1.14
Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation (2000) 1.13
Aneurysm of the ascending aorta presenting with pulmonary stenosis. Thorax (1966) 1.13
Outcome of non-elective coronary artery bypass grafting without cardio-pulmonary bypass. Eur J Cardiothorac Surg (2001) 1.13
Chronic haemolysis following insertion of ball valve prostheses. Br Heart J (1968) 1.13
Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol (1997) 1.13
The accumulation of immunoblasts in extravascular tissues including mammary gland, peritoneal cavity, gut and skin. Immunology (1978) 1.13
Risk of lymphoid neoplasia after cardiothoracic transplantation. a cohort study of the relation to Epstein-Barr virus. Transplantation (2000) 1.12
Can graft endothelial cells initiate a host anti-graft immune response? Transplantation (1996) 1.12
Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension. J Pathol (2000) 1.12
Left ventricular contractility and contractile reserve in humans after cardiac transplantation. Circulation (1985) 1.11
Developmental expression of troponin I isoforms in fetal human heart. FEBS Lett (1991) 1.10
Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells. Circulation (2000) 1.10
The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis. Respir Res (2001) 1.10
Late endothelial function of free and pedicled internal mammary artery grafts. J Thorac Cardiovasc Surg (1995) 1.10
Dehiscence of infected aortocoronary vein graft suture lines. Cause of late pseudoaneurysm of ascending aorta. Br Heart J (1983) 1.09
Effects of valve substitute on changes in left ventricular function and hypertrophy after aortic valve replacement. Ann Thorac Surg (1996) 1.08
Expression of class I and class II MHC antigens in normal and transplanted human lung. Transplant Proc (1989) 1.08
Heat shock treatment enhances graft cell survival in skeletal myoblast transplantation to the heart. Circulation (2000) 1.08
Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium and skin. J Heart Valve Dis (2000) 1.07